comparemela.com

Latest Breaking News On - Bharat biotech chairman - Page 6 : comparemela.com

Bharat Biotech's Covaxin 81% effective, works against UK variant

Bharat Biotech's Covaxin 81% effective, works against UK variant
origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.

India
United-kingdom
Bharat
Krishna-ella
Suchitra-ella
Serum-institute-covishield
National-institute-of-virology
Indian-council-of-medical-research
Bharat-biotech
Serum-institute
Indian-council
Medical-research

65 percent of vaccines manufactured in Hyderabad: Krishna Ella

65 percent of vaccines manufactured in Hyderabad: Krishna Ella By IANS|   Posted by Sameer  |   Published: 23rd February 2021 10:49 am IST IANS Hyderabad: Almost 65 percent of all vaccines manufactured in India and exported around the world come from Hyderabad, Bharat Biotech Chairman, and Managing Director Dr. Krishna Ella said on Monday. He said that there is no cluster like Hyderabad’s Genome Valley anywhere in the world which contributes such huge volumes. He was speaking after receiving Genome Valley Excellence Award at the inaugural session of Bio Asia 2021, the 18th edition of Asia’s biggest life science and healthcare industry conference. Dr Krishna Ella and Bharat Biotech’s Joint Managing Director Suchitra Ella received the award from Telangana’s Industry Minister K. T. Rama Rao.

Hyderabad
Andhra-pradesh
India
Bengaluru
Karnataka
Telangana
Bharat
Indian-immunologicals
Kt-rama-rao
Aurobindo-pharma
Krishna-ella
Bio-asia

65% of vaccines manufactured in Hyderabad, says Krishna Ella

65% of vaccines manufactured in Hyderabad, says Krishna Ella ​ By IANS | Published on ​ Mon, Feb 22 2021 18:03 IST | ​ 1 Views 65 percent of vaccines are manufactured in Hyderabad, says Krishna Ella. Image Source: IANS News Hyderabad, Feb 22 : Almost 65 per cent of all vaccines manufactured in India and exported around the world come from Hyderabad, Bharat Biotech Chairman and Managing Director Dr Kishna Ella said on Monday. He said that there is no cluster like Hyderabad s Genome Valley anywhere in the world which contributes such huge volumes. He was speaking after receiving Genome Valley Excellence Award at the inaugural session of Bio Asia 2021, the 18th edition of Asia s biggest life science and healthcare industry conference.

Hyderabad
Andhra-pradesh
India
Bengaluru
Karnataka
Telangana
Bharat
Indian-immunologicals
Kt-rama-rao
Kishna-ella
Aurobindo-pharma
Krishna-ella

65% of vaccines manufactured in Hyderabad, says Bharat Biotech's Krishna Ella

65% of vaccines manufactured in Hyderabad, says Bharat Biotech s Krishna Ella SECTIONS Last Updated: Feb 22, 2021, 06:20 PM IST Share Synopsis Krishna Ella, whose firm developed India s first indigenous vaccine for Covid-19, said pandemic vaccines and everything in future will come from Hyderabad . Bharat Biotech received the award for breakthrough, pioneering research, development and commercialization of vaccines. 2,944,771.0 Almost 65 per cent of all vaccines manufactured in India and exported around the world come from Hyderabad, Bharat Biotech Chairman and Managing Director Dr Kishna Ella said on Monday. He said that there is no cluster like Hyderabad s Genome Valley anywhere in the world which contributes such huge volumes.

Hyderabad
Andhra-pradesh
India
Bengaluru
Karnataka
Telangana
Bharat
Indian-immunologicals
Kt-rama-rao
Kishna-ella
Aurobindo-pharma
Krishna-ella

Bharat Biotech hails Rs 35,000 crore budget allocation for COVID-19 vaccination

Bharat Biotech hails Rs 35,000 crore budget allocation for COVID-19 vaccination SECTIONS Last Updated: Feb 01, 2021, 05:29 PM IST Share Synopsis Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22. Getty Images Hyderabad: Covaxin maker Bharat Biotech on Monday described as far reaching initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease. Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with something in it for everyone .

India
Hyderabad
Andhra-pradesh
Bharat
Oxford-covishield
Reddyk-satish-reddy
Krishna-ella
National-research-foundation
Rd-research
Reddys-laboratories-ltd
Union-budget
National-health-mission

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.